This CPD activity is supported by an unrestricted education grant by Reckitt.[/caption]
Jess Hadley, community pharmacist and Professional Officer at PDL[/caption]
Peter Guthrey, Senior Pharmacist – Strategic Policy at PSA[/caption]
Professor Margie Danchin[/caption]
Dr Peter Tenni[/caption]
How should we deprescribe gabapentinoids, according to the Maudsley Deprescribing Guidelines[/caption]
From the President: pharmacist prescribing
Prescribing is more than just putting pen to paper – but falls well within pharmacists’ scope of practice.
Adding prescribing to the repertoire of the...
Not Yet Equal
The LGBTQIA+ community experiences poorer health outcomes than other Australians. As Sydney plays host to the WorldPride festival in February and March, it’s time for the entire health system – including pharmacists – to step up.
Management of apathy in patients with Alzheimer’s disease
People diagnosed with Alzheimer’s disease often experience symptoms of apathy, which can be treated by pharmacological and behavioural interventions.
The purpose of this evidence...
Groups raise fears over Qld pharmacy deregulation
Submissions to the current Queensland Government inquiry into pharmacy ownership and regulation in the state have resoundingly supported current ownership provisions, amid concerns that...
Remote Australians at increased risk for diabetes complications
Mortality rates are four times higher for Indigenous patients with diabetes than non-Indigenous Australians, a report has found.
The Australian Institute of Health and Welfare...
Calculating the risk of glaucoma
More than 1000 people have completed an online assessment in Australian pharmacies to determine their potential risk of developing glaucoma, and there's a call...
